Highest Yielding Marijuana Cannabis Pot Stocks

Please note that this is a sister publication of WallStreetNewsNetwork ( http://WStNN.com ) and eventually everything on this site will be transferred over there.
by Fred Fuld III

You may have seen some of the major gains in some of the marijuana stocks and wanted to jump on the bandwagon. As an example, Cronos (CRON) has increased by 13% so far this year and Aurora (ACB) rose 26% even after experiencing a big drop during the last six months.

Maybe you are a relatively conservative investor and you want to receive a dividend in return for the risk you are taking. Fortunately, there are several cannabis stocks that provide investors with a yield.

Scotts Miracle-Gro Company (SMG) has a couple divisions in the marijuana industry. Its Hawthorne Gardening Co. subsidiary purchased General Hydroponics which makes and markets products for the pot growers. The company has also invested in the hydroponics company AeroGrow International (AERO) which markets to the small scale grower. Scotts’ current yield is 2.17%, with the latest dividend of 58 cents paid September 10 (today), an incense of 5.5% over the previous quarter. The dividend has increased on an annual basis since 2015.

AbbVie Inc. (ABBV), the marketer of Marinol also known as Dronabinol, a form of tetrahydrocannabinol, one of the main psychoactive ingredients of marijuana. The company has been paying quarterly dividends and has increased the annual dividend every year since 2013. AbbVie’s annual forward dividend yield is 6.28%. The company’s most recent dividend is $1.07 per share, which will be paid to investors on November 15, 2019 to shareholders of record on October 11.

Innovative Industrial Properties Inc. (IIPR), which trades on the New York Stock Exchange,  owns, manages, and leases properties to state licensed cannabis growing facilities. Annual dividends since 2017 were 55 cents, $1.20, and $2.40. The dividends are paid quarterly, currently 60 cents per share, up from 45 cents for the previous quarter, an increase of 33%. The company pays a dividend yield of 2.79%.

Altria (MO) is the tobacco company that manufactures and markets cigarettes and smokeless tobacco. The company invested over a billion dollars in Cronos Group (CRON), the Canadian marijuana company. The stock has a forward yield of 7.9%.

Molson Coors (TAP) is the seventh largest brewer in the world. The company is in partnership with HEXO (HEXO) to produce cannabis-infused beverages in Canada. Molson Coors yields 4.03%.

Horizons Marijuana Life Sciences Index ETF (HMLSF) is an exchange traded fund that invests in many companies involved in the marijuana industry. It has a yield of 7.54%.

Constellation Brands (STZ), the beer, wine, and liquor producer, has a significant ownership in the Ontario, Canada based cannabis company Canopy Growth (CGC). Constellation has a dividend yield of 1.44%.

Let’s hope some of these stocks get high, and provide you with a smoking portfolio.

Don’t forget to read:

Exclusive Interview with Chet Billingsley CEO of Mentor Capital on the Marijuana Industry

Is Apple Getting into the Marijuana Industry?

Disclosure: Author owns CGC and a long option position in ACB.



INVESTMENT TRIVIA 2019  
 
MAKES A GREAT GIFT!!!

Nasdaq Denies Cannabis Technology Company MassRoots; Shuns the Regulated Cannabis Industry

Denver, CO (May 25, 2016): MassRoots (OTCQB: MSRT), one of the largest and fastest growing technology platforms for the cannabis industry, received notification on Monday, May 23, 2016, that the Nasdaq will be denying MassRoots’ application for listing. The Nasdaq determined that as MassRoots may be deemed as aiding and abetting the distribution of an illegal substance, they are unwilling to proceed with MassRoots’ listing application. MassRoots plans to appeal the staff decision to the Nasdaq Listing and Hearings Review Panel.

“With this decision, the Nasdaq has set a dangerous precedent that will prevent nearly every company in the regulated cannabis industry from listing on a national exchange. This will have ripple effects across the entire industry, making it more difficult for cannabis entrepreneurs to raise capital and slow the progression of cannabis legalization in the United States,” stated MassRoots CEO Isaac Dietrich. “This decision must not be allowed to stand and we’re asking every cannabis investor, business, activist and supporter to write a brief note to the Nasdaq in support of our appeal here.”

“If we were a social network for tobacco users or alcohol consumers, the Nasdaq would likely be moving forward on our application even though alcohol and tobacco cause far more deaths and societal damage than cannabis ever will.  Moreover, the Nasdaq has already listed at least 4 biotechnology companies that extract compounds from the cannabis plant for scientific research – actually touching the plant as part of their business model,” continued Dietrich. “We believe the Nasdaq has inappropriately denied our application and look forward to making our case not just to the Nasdaq Listing and Hearings Review Panel, but directly to the American public.”

MassRoots has requested the Nasdaq’s denial letter in writing and will file an 8-K within 4 business days of receipt. The Company plans to appeal the Nasdaq’s decision shortly thereafter. MassRoots will not be affecting a reverse stock split unless its appeal from the Nasdaq is granted.

About MassRoots

MassRoots is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with 900,000 users. It is proud to be affiliated with the leading organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots has been covered by the Financial Times, Forbes, Fox Business, Bloomberg, Fortune, and CNBC. For more information, please visit MassRoots.com/Investors.

This information does not constitute an offer to sell or a solicitation of an offer to buy securities or assets of MassRoots. All information presented herein with respect to the existing business and the historical operating results of MassRoots and estimates and projections as to future operations, the success of events that we are attending, and other information, is based on materials prepared by the management of MassRoots and involve significant elements of subjective judgment and analysis which may or may not be correct. While the information provided herein is believed to be accurate and reliable, MassRoots makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. In furnishing this information, MassRoots reserves the right to amend or replace some or all of the information herein at any time and undertakes no obligation to provide the recipient with access to any additional information.  

Forward-looking Statements:

Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots' advertising business, potential partnerships, and our related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Important factors that could cause our actual results to differ materially from those anticipated by the statements made herein include, among others, the success of our advertising initiatives, the continued growth and engagement of our user base, our ability to work with partners of the Company, and unforeseen technical or other problems or issues that could affect the performance of our products or our business. Further information on our risk factors is contained in our filings with the SEC, including the Amendment to our S-1 Registration Statement filed on October 29, 2015. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.

Marijuana Stocks Crash in April

If you have been following the Stockerblog.com Marijuana Stock Index, which can be found at WallStreetNewsNetwork.com, over the last few months, you would notice that the pot stocks increased substantially during the first couple months of the year. However, during the month of March, the cannabis companies started to drop off, and in April, they really tanked.

According to the Marijuana Index, a dozen of the 21 stocks in the index dropped in excess of 30% over the last couple months, with several dropping by over 50%. For example, Advanced Cannabis Solutions (CANN) dropped by 53%, Cannabis Science Inc. (CBIS) dropped by a similar amount, and CannaVEST (CANV) fell by 87%.

The overall Marijuana Stock Index tanked by 43% during the last two months, whereas the S&P 500 was up by 1%. Interestingly, the Marijuana Stock Index is still outperforming the S&P 500 from the beginning of the year, with the Marijuana Index up 17% and the S&P up just 2%. Some of the stock are still up substantially from the beginning of the year in spite of the March and April drop, with more than ten rising over 100%.

To see the free list of all 21 stocks in the entire Stockerblog.com Marijuana Stock Index, go to WallStreetNewsNetwork.com. Also available is the Big List of marijuana stocks, which has over 100 cannabis stocks.

Disclosure: Author didn't own any of the above at the time the article was written. 

By Stockerblog.com